S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea flag South Korea · Delayed Price · Currency is KRW
20,350
-850 (-4.01%)
At close: Oct 22, 2026

S.Biomedics Revenue

S.Biomedics had revenue of 4.82B KRW in the quarter ending June 30, 2026, with 0.19% growth. This brings the company's total for the last twelve months to 16.49B, down -3.53% year-over-year. In the year 2025, S.Biomedics had annual revenue of 16.55B with 20.49% growth. That makes S.Biomedics the 36,313th largest company in the world by revenue and 2,325th in South Korea.

Revenue (ttm)
16.49B
Revenue Growth
-3.53%
P/S Ratio
15.28
Revenue / Employee
358.53M
Employees
46
Market Cap
252.04B

Revenue Chart

Revenue by Geography

  • South Korea 15.88B 96.0%
  • Overseas 664.70M 4.0%
Fiscal year ended Dec 31, 2025 See the full S.Biomedics breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202516.55B2.81B20.49%
Dec 31, 202413.73B625.65M4.77%
Dec 31, 202313.11B995.73M8.22%
Dec 31, 202212.11B3.24B36.58%
Dec 31, 20218.87B3.55B66.72%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
HansBiomed124.81B
ROKIT Healthcare32.81B
Genome & Company24.46B
NIBEC22.60B
curacle co.,ltd.8.24B
IntoCell3.19B
Kangstem Biotech3.03B
Inventage Lab2.47B
Revenue Rankings